Skip to content
Insmed
-
Insmed’s Brinsupri stumbles again in second failed trial in four months
This setback follows Brinsupri’s unsuccessful phase 2 trial for chronic rhinosinusitis without nasal polyps, which also failed to meet its primary and secondary endpoints at both tested doses.